This knowledge of p53‐immunoreactivity on immunohistochemistry in PML could prevent the misdiagnosis of infiltrating astrocytomas and strengthen the diagnosis of PML. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).